TD
Tobii Dynavox AB (publ)
TDVXF · OTC
$6.65 -11.33% (-$0.85)
1M -1.96%
Market Cap 6.94B kr
P/E Ratio 30.75x
Div. Yield 0.81%
ROE 35.95%
Bulios Fair Price
$9.21
38.5% upside
Current Price
$6.65
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TDVXF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
38 /100
Fair P/E 30.75x
EV/EBITDA 15.61x
P/S 2.74x
Growth
100 /100
Growing EPS growth 50.24%
Rev. growth 26.58%
Book val. growth 42.00%
Profitability
67 /100
Strong Gross margin 68.95%
Net margin 8.90%
Op. margin 12.80%
Quality
82 /100
Excellent ROIC 12.86%
ROE 35.95%
ROA 8.60%
Debt
63 /100
Moderate Debt/Equity 1.55x
Current ratio 1.59x
Int. coverage 9.81x
Stability
81 /100
Stable Beta 0.81x
Rev. volatility 5.37%
EPS volatility 51.43%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TDVXF
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Fredrik Ruben
Employees
1,063
Headquarters
Stockholm
Upcoming events
21 OCT
Earnings
Upcoming earnings report